Randomised controlled trial of Levosimendan vs Enoximone in Cardiogenic Shock

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN87369174

Enrollment

Registered

2004-09-30

Start date

2004-05-01

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular: Cardiogenic shock Circulatory System Cardiogenic shock

Interventions

Following assessment by the duty Consultant Intensivist invasive monitoring will be placed as part of the current standard clinical practice. All those satisfying both the inclusion and exclusion crit

Eligibility

Inclusion criteria

Inclusion criteria: 1. Patients over 18 years of age. 2. All patients that are suspected of having cardiogenic shock during their admission to the Critical Care Unit will be identified.

Exclusion criteria

Exclusion criteria: Not provided at time of registration

Design outcomes

Primary

Measure	Time frame
Not provided at time of registration	—

Secondary

Measure	Time frame
Not provided at time of registration	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026